6505--Contingency Medication Compounding Services

SOL #: 36C25626Q0332Combined Synopsis/Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
256-NETWORK CONTRACT OFFICE 16 (36C256)
RIDGELAND, MS, 39157, United States

Place of Performance

Houston, TX

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 6, 2026
2
Last Updated
Feb 11, 2026
3
Submission Deadline
Feb 16, 2026, 9:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Michael E. Debakey VA Medical Center in Houston, TX, is seeking Emergency Contingency Services for Hazardous and Non-Hazardous Medication Compounding. This is an unrestricted combined synopsis/solicitation (RFQ) for commercial products and services. The contract will be a Firm-Fixed Price, Indefinite-Delivery-Indefinite-Quantity award. Quotes are due February 16, 2026.

Scope of Work

The requirement includes providing contingency services for medication compounding, specifically:

  • Provision of hazardous and non-hazardous agents, IV tubing, closed system drug transfer devices, and other necessary items.
  • Aseptic compounding of agents based on patient-specific orders.
  • Transportation of compounded orders via courier, overnight mail, or other means to ensure timely delivery.
  • Compliance with USP 797, USP 800, and Federal Law for compounding, labeling, and beyond-use dating/expiration dating.
  • Submission of current and future certification reports for sterile compounding areas and hoods.
  • Annual submission of the "VHA PBM Assessment Guide for Compounded Sterile Preparations within VAMCs and Outsourced Compounding Pharmacies."

Contract & Timeline

  • Contract Type: Firm-Fixed Price, Indefinite-Delivery-Indefinite-Quantity (IDIQ)
  • Period of Performance: One year from the date of award.
  • Set-Aside: Unrestricted
  • NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing), with a small business size standard of 1,300 employees.
  • Product Service Code (PSC): 6505 (Drugs And Biologicals)
  • Place of Performance: Michael E. Debakey VAMC, Houston, TX.
  • Questions Due: February 10, 2026, by 12:00 PM CST.
  • Quotes Due: February 16, 2026, by 3:00 PM CST.
  • Published: February 6, 2026.

Evaluation

Award will be made on a Lowest Price Technically Acceptable (LPTA) basis, resulting in a Firm-Fixed Priced Award. Evaluation factors include:

  • Technical: Brand Name or Equal, Contingency Plan.
  • Price.

Additional Notes

All questions must be submitted via email to Contract Specialist Eugene Jackson at Eugene.Jackson2@va.gov. Quotes must also be submitted electronically to the same email address, with the subject line "RFQ 36C25626Q0332–Pharmacy Contingency Contract for Hazardous and Non-Hazardous Compounding." Offerors must complete annual representations and certifications electronically via SAM.gov.

People

Points of Contact

Eugene JacksonContract SpecialistPRIMARY

Files

Files

Download

Versions

Version 4
Combined Synopsis/Solicitation
Posted: Feb 11, 2026
View
Version 3
Combined Synopsis/Solicitation
Posted: Feb 6, 2026
View
Version 2Viewing
Combined Synopsis/Solicitation
Posted: Feb 6, 2026
Version 1
Combined Synopsis/Solicitation
Posted: Feb 6, 2026
View